Form 4: Clorox Director Stephanie Plaines Acquires Stock Units

Stephanie Plaines, a Director at The Clorox Company, acquired deferred stock units through dividend reinvestment and in lieu of director's fees, as reported in a Form 4 filing.

Summary

• Stephanie Plaines, a Director at The Clorox Company (CLX), reported transactions involving deferred stock units on June 30, 2026.
• These units were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan.
• Additionally, Plaines received deferred stock units in lieu of her quarterly director's fees.
• The deferred stock units are set to be settled 100% in Clorox stock upon her retirement or termination of service as a Director.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider transactions related to director compensation rather than significant strategic or financial events.

Positives

• Director Stephanie Plaines's acquisition of deferred stock units indicates continued alignment with the company's performance and future prospects.
• The acquisition of units in lieu of fees suggests a commitment to deferring compensation into equity, aligning director interests with shareholders.
• The settlement of deferred stock units in Clorox stock upon retirement reinforces long-term commitment.

Negatives

• The filing does not contain any negative financial or operational information.

Risks

• The value of the deferred stock units is subject to the future performance of Clorox's stock price.
• Potential for changes in the Independent Directors' Deferred Compensation Plan or company policies affecting future acquisitions.

Future Outlook

The deferred stock units acquired by Stephanie Plaines will be settled in Clorox stock upon her retirement or termination of service as a Director, indicating a long-term outlook tied to the company's equity value.

Management Comments

• The filing details the acquisition of deferred stock units through dividend reinvestment and in lieu of director's fees, reflecting standard compensation practices for directors.
• The settlement of these units in Clorox stock upon termination of service highlights the intention to align director compensation with shareholder value over the long term.

Industry Context

StockSavvy.ai notes that insider transactions, such as the acquisition of deferred stock units by directors, are common in the consumer staples industry. These actions often signal confidence in the company's long-term prospects and are a standard mechanism for aligning executive and director compensation with shareholder interests.

Corporate Governance

Related Party Transactions

• Stephanie Plaines, a Director, acquired deferred stock units in lieu of her quarterly director's fees, which is a form of compensation transaction between the company and a related party (director).

Stakeholder Impact

• Shareholders: The acquisition of stock units by a director can be seen as a positive signal of confidence in the company's future performance.
• Employees: No direct impact is indicated for employees.
• Management: Standard compensation practice for directors, reinforcing governance structures.

Next Steps

• Settlement of deferred stock units in Clorox stock upon Stephanie Plaines's retirement or termination of service as a Director.

Key Dates

Keywords

Clorox, CLX, Form 4, Stephanie Plaines, Director, Deferred Stock Units, Insider Trading, SEC Filing, Compensation, Equity